avanti polar lipids/18:1 Biotinyl Cap PE/200mg/870273P-200mg,avanti polar lipids,,Avanti Polar,Avanti,avantilipids,Avanti Polar Lipids Inc,Avanti中国试剂购买网站 Avanti Polar Lipids天然提取脂类,,Array.Array.Array蚂蚁淘厂家直采.

产品名称：avanti polar lipids/18:1 Biotinyl Cap PE/200mg/870273P-200mg

产品编号：870273P-200mg

市场价：¥17000.00

场地：美国(厂家直采)

产品分类：生化试剂>其他>酯>

联系QQ：1570468124

电话号码：4000-520-616

邮箱： info@ebiomall.com

美元价：$850.00

品牌： avanti polar lipids

公司：Avanti Lipids Polar, Inc.

公司分类：

商品介绍

870273 | 18:1 Biotinyl Cap PE

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt)

Info

18:1 Biotinyl Cap PE

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt)

Data

Hygroscopic

Yes

Light Sensitive

Molecular Formula

C₅₇H₁₀₂N₄O₁₁PNaS

Percent Composition

C 61.93%, H 9.30%, N 5.07%, Na 2.08%, O 15.92%, P 2.80%, S 2.90%

Purity

>99%

Stability

1 Year

Storage Temperature

-20°C

CAS Number

384835-51-2 CAS Registry Number is a Registered Trademark of the American Chemical Society

FormulaWeight

1105.469

Exact Mass

1104.69

Synonyms

1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt)

Downloads

ChemDraw File
3D Structure
Structure
Safety Data Sheet

References

Olżyńska A, Kulig W, Mikkolainen H, Czerniak T, Jurkiewicz P, Cwiklik L, Rog T, Hof M, Jungwirth P, Vattulainen I. Tail-Oxidized Cholesterol Enhances Membrane Permeability for Small Solutes. Langmuir. 2020 Aug 28. doi: 10.1021/acs.langmuir.0c01590. Epub ahead of print. PMID: 32804507.

PubMed ID: 32804507

Alberdi L, Vergnes A, Manneville JB, Tembo DL, Fang Z, Zhao Y, Schroeder N, Dumont A, Lagier M, Bassereau P, Redondo-Morata L, Gorvel JP, Méresse S. Regulation of kinesin-1 activity by the Salmonella enterica effectors PipB2 and SifA. J Cell Sci. 2020 May 14;133(9):jcs239863. doi: 10.1242/jcs.239863. PMID: 32409568.

PubMed ID: 32409568

Cao F, Zhou Y, Liu X, Yu CH. Podosome formation promotes plasma membrane invagination and integrin-β3 endocytosis on a viscous RGD-membrane. Commun Biol. 2020 Mar 13;3(1):117. doi: 10.1038/s42003-020-0843-2. PMID: 32170110; PMCID: PMC7070051.

PubMed ID: 32170110

Lamichhane R, Liu JJ, White KL, Katritch V, Stevens RC, Wüthrich K, Millar DP. Biased Signaling of the G-Protein-Coupled Receptor β2AR Is Governed by Conformational Exchange Kinetics. Structure. 2020 Jan 23:S0969-2126(20)30001-0. doi: 10.1016/j.str.2020.01.001. Epub ahead of print. PMID: 31978323.

PubMed ID: 31978323

Zhang DKY, Cheung AS, Mooney DJ. Activation and expansion of human T cells using artificial antigen-presenting cell scaffolds. Nat Protoc. 2020 Jan 13:10.1038/s41596-019-0249-0. doi: 10.1038/s41596-019-0249-0. Epub ahead of print. PMID: 31932772.

PubMed ID: 31932772

Pyrpassopoulos S, Shuman H, Ostap EM. Modulation of Kinesin"s Load-Bearing Capacity by Force Geometry and the Microtubule Track. Biophys J. 2020 Jan 7;118(1):243-253. doi: 10.1016/j.bpj.2019.10.045. Epub 2019 Dec 12. PMID: 31883614; PMCID: PMC6952184.

PubMed ID: 31883614

Tsemperouli M, Amstad E, Sakai N, Matile S, Sugihara K. Black Lipid Membranes: Challenges in Simultaneous Quantitative Characterization by Electrophysiology and Fluorescence Microscopy. Langmuir. 2019 Jul 2;35(26):8748-8757. doi: 10.1021/acs.langmuir.9b00673. Epub 2019 Jun 20.

PubMed ID: 31244250

Scarborough EA, Davis TN, Asbury CL. Tight bending of the Ndc80 complex provides intrinsic regulation of its binding to microtubules. Elife. 2019 May 2;8. pii: e44489. doi: 10.7554/eLife.44489.

PubMed ID: 31045495

Kubicek-Sutherland JZ, Vu DM, Noormohamed A, Mendez HM, Stromberg LR, Pedersen CA, Hengartner AC, Klosterman KE, Bridgewater HA, Otieno V, Cheng Q, Anyona SB, Ouma C, Raballah E, Perkins DJ, McMahon BH, Mukundan H. Direct detection of bacteremia by exploiting host-pathogen interactions of lipoteichoic acid and lipopolysaccharide. Sci Rep. 2019 Apr 17;9(1):6203. doi: 10.1038/s41598-019-42502-5.

PubMed ID: 30996333

Coker HLE, Cheetham MR, Kattnig DR, Wang YJ, Garcia-Manyes S, Wallace MI. Controlling Anomalous Diffusion in Lipid Membranes. Biophys J. 2019 Mar 19;116(6):1085-1094. doi: 10.1016/j.bpj.2018.12.024. Epub 2019 Jan 16.

PubMed ID: 30846364

Colin-York H, Javanmardi Y, Skamrahl M, Kumari S, Chang VT, Khuon S, Taylor A, Chew TL, Betzig E, Moeendarbary E, Cerundolo V, Eggeling C, Fritzsche M. Cytoskeletal Control of Antigen-Dependent T Cell Activation. Cell Rep. 2019 Mar 19;26(12):3369-3379.e5. doi: 10.1016/j.celrep.2019.02.074.

PubMed ID: 30893608

Emilsson G, Röder E, Malekian B, Xiong K, Manzi J, Tsai FC, Cho NJ, Bally M, Dahlin A. Nanoplasmonic Sensor Detects Preferential Binding of IRSp53 to Negative Membrane Curvature. Front Chem. 2019 Feb 4;7:1. doi: 10.3389/fchem.2019.00001. eCollection 2019.

PubMed ID: 30778383

Di Iorio D, Verheijden ML, van der Vries E, Jonkheijm P, Huskens J. Weak Multivalent Binding of Influenza Hemagglutinin Nanoparticles at a Sialoglycan-Functionalized Supported Lipid Bilayer. ACS Nano. 2019 Mar 12. doi: 10.1021/acsnano.8b09410. [Epub ahead of print]

PubMed ID: 30844236

Chen A, Yang D, Xuan X, Miller H, Luo X, Yu J, Yang G, Wang H, Liu C. Dock5 controls the peripheral B cell differentiation via regulating BCR signaling and actin reorganization. Cell Immunol. 2019 Mar;337:15-21. doi: 10.1016/j.cellimm.2019.01.001. Epub 2019 Jan 11.

PubMed ID: 30661670

Wan Z, Shao X, Ji X, Dong L, Wei J, Xiong Z, Liu W, Qi H. Transmembrane domain-mediated Lck association underlies bystander and costimulatory ICOS signaling. Cell Mol Immunol. 2018 Dec 6. doi: 10.1038/s41423-018-0183-z. [Epub ahead of print]

PubMed ID: 30523347

Sathyanarayanan G, Haapala M, Sikanen T. Interfacing Digital Microfluidics with Ambient Mass Spectrometry Using SU-8 as Dielectric Layer. Micromachines (Basel). 2018 Dec 8;9(12). pii: E649. doi: 10.3390/mi9120649.

PubMed ID: 30544772

Yu Y, Gao Y, Yu Y. "Waltz" of Cell Membrane-Coated Nanoparticles on Lipid Bilayers: Tracking Single Particle Rotation in Ligand-Receptor Binding. ACS Nano. 2018 Nov 13. doi: 10.1021/acsnano.8b04880. [Epub ahead of print]

PubMed ID: 30421608

Amadei F, Fröhlich B, Stremmel W, Tanaka M. Non-Classical Interactions of Phosphatidylcholine with Mucin Protect Intestinal Surfaces: A Microinterferometry Study. Langmuir. 2018 Oct 25. doi: 10.1021/acs.langmuir.8b03035. [Epub ahead of print]

PubMed ID: 30359036

Piffoux M, Silva AKA, Wilhelm C, Gazeau F, Tareste D. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems. ACS Nano. 2018 Jul 10. doi: 10.1021/acsnano.8b02053. [Epub ahead of print]

PubMed ID: 29975503

Wang M, Liu Z, Zhan W. Janus Liposomes: Gel-Assisted Formation and Bioaffinity-Directed Clustering. Langmuir. 2018 Jun 12. doi: 10.1021/acs.langmuir.8b00798. [Epub ahead of print]

PubMed ID: 29852065

Liu, C., H. Miller, K.L. Hui, B. Grooman, S. Bolland, A. Upadhyaya, and W. Song. (2011). A balance of Bruton"s tyrosine kinase and SHIP activation regulates B cell receptor cluster formation by controlling actin remodeling. J Immunol 187:230-9.

PubMed ID: 21622861

Liu, C., H. Miller, G. Orlowski, H. Hang, A. Upadhyaya, and W. Song. (2012). Actin reorganization is required for the formation of polarized B cell receptor signalosomes in response to both soluble and membrane-associated antigens. J Immunol 188:3237-46.

PubMed ID: 22387556

Phase Composition Control in Microsphere-Supported Biomembrane Systems Eric S. Fried, Yue-ming Li, and Malcolm Lane Gilchrist Langmuir, Just Accepted Manuscript DOI: 10.1021/acs.langmuir.6b04150 Publication Date (Web): February 15, 2017 Copyright © 2017 American Chemical Society

PubMed ID: 28198634

Maria J. Sarmento, Ana Coutinho, Aleksander Fedorov, Manuel Prieto, and Fabio Fernandes. Membrane Order Is a Key Regulator of Divalent Cation-Induced Clustering of PI(3,5)P2 and PI(4,5)P2. Langmuir. Article ASAP.

PubMed ID: 28961003

Shindell O, Mica N, Cheng KH, Wang E, Gordon VD. Dynamic Fingering in Adhered Lipid Membranes. Langmuir. 2018 Feb 7. doi: 10.1021/acs.langmuir.7b03708. [Epub ahead of print]

PubMed ID: 29363972

Certificates of Analysis

Certificate of Analysis(Lot No. 870273C-200MG-A-064and 6177PNA064)
Certificate of Analysis(Lot No. 870273C-25MG-A-063and 6177CJA063)
Certificate of Analysis(Lot No. 870273P-200MG-A-064and 6177PNA064)
Certificate of Analysis(Lot No. 870273P-25MG-A-063and 6177PJA063)
Certificate of Analysis(Lot No. 870273C-25MG-A-064and 6177CJA064)
Certificate of Analysis(Lot No. 870273P-200MG-B-064and 6177PNB064)
Certificate of Analysis(Lot No. 870273P-25MG-A-064and 6177PJA064)
Certificate of Analysis(Lot No. 870273P-25MG-A-065and 6177PJA065)
Certificate of Analysis(Lot No. 870273C-25MG-A-065and 6177CJA065)
Certificate of Analysis(Lot No. 870273P-25MG-B-065and 6177PJB065)
Certificate of Analysis(Lot No. 870273P-25MG-C-065and 6177PJC065)
Certificate of Analysis(Lot No. 870273C-25MG-B-065and 6177CJB065)
Certificate of Analysis(Lot No. 870273C-25MG-B-064and 6177CJB064)
Certificate of Analysis(Lot No. 870273P-25MG-D-065and 6177PJD065)
Certificate of Analysis(Lot No. 870273P-25MG-E-065and 6177PJE065)
Certificate of Analysis(Lot No. 870273C-25MG-A-066and 6177CJA066)
Certificate of Analysis(Lot No. 870273C-25MG-D-066and 6177CJD066)
Certificate of Analysis(Lot No. 870273C-25MG-E-066and 6177CJE066)
Certificate of Analysis(Lot No. 870273P-25MG-B-066and 6177PJB066)
Certificate of Analysis(Lot No. 870273C-25MG-F-066and 6177CJF066)

Base Price:${originalprice|money}

Custom Packaging:(${concentration} @$4.00/ea. + $100)${custompackagingtotal|money}

Packaging:${concentration}

Item Total:${totalprice|money}

(Sales Tax may apply)

Please select an option above.

Selected Product${sku} - ${concentration}

品牌介绍

Avanti Polar Lipids.jpg

Avanti Polar Lipids公司是美国著名的磷脂类产品的生产商，该公司主要为各种制药厂和研究机构提供从毫克级到公斤级乃至吨级的磷脂类和甾体类中间体和试剂。为世界范围内的研究机构和制药公司提供 1000 种以上脂类产品，由于其产品的高纯度而享誉全球。40年来，Avanti Polar Lipids公司为世界各地的研究人员和制药公司提供脂类产品。公司的产品不仅范围日益扩大，其纯度之高也是无人能及。

Avanti Polar Lipids, Inc., has a long history of 50 years creating the highest purity lipids available. Our passion for high quality and unique products is only exceeded by our excellent reputation in the marketplace. Although we are known for our lipids, we are More than Lipids. We offer solutions for the entire product cycle…Research to Commercialization.

Avanti Polar Lipids公司的主要产品和服务包括：

（1）Research Products

Highest Purity Lipid Reagents

（2）cGMP Manufacturing

API & Contract Manufacturing

（3）Adjuvants

Immunotherapy & Vaccine Development

（4）Analytical Services

Lipid Analysis

（5）Lipidomics

Mass Spec Standards, Antibodies & Lipid Toolbox

（6）Formulations